Macrophages in Atheromatous Plaque Developmental Stages

Area of Science:

• Cardiovascular Research
• Immunology
• Pathology

Background:

• Atherosclerosis is a primary cause of cardiovascular diseases, including myocardial infarction and stroke.
• It is increasingly recognized as a chronic inflammatory disease, not solely metabolic.
• Macrophages are the most abundant inflammatory cells in atherosclerotic lesions, crucial throughout atherogenesis.

Purpose of the Study:

• To review the trafficking, fate, and functions of diverse macrophage populations in atheromatous plaque development.
• To provide a comprehensive overview of macrophage involvement across the plaque life cycle.

Main Methods:

• Review of current literature on macrophage biology in atherosclerosis.
• Analysis of transcriptomic data to classify macrophage populations.
• Integration of knowledge on immune cell roles in atherogenesis.

Main Results:

• Macrophage populations in atherosclerosis can be classified by origin (resident, yolk sac, fetal liver, postnatal monocyte-derived) or function (resident, inflammatory, foamy).
• Macrophages exhibit distinct roles and behaviors at different stages of plaque formation and progression.
• Transcriptomic analyses highlight key functional macrophage subtypes within atherosclerotic lesions.

Conclusions:

• Understanding the heterogeneity and function of macrophages is essential for targeting atherosclerotic plaque growth.
• Targeting the chronic inflammatory state within atherosclerotic lesions offers therapeutic potential beyond cholesterol reduction.
• Further research into macrophage dynamics may lead to novel strategies for plaque regression and cardiovascular disease prevention.